TRACK BRANDS ON AI
Monitor your brand, company, or product's online reputation in AI responses
Searching...
Loading...
It's taking longer than usual, we might be experiencing higher load.
Give it a few more seconds or try again in a moment.
Give it a few more seconds or try again in a moment.
Searching...
Loading...
What does AI know about Ultragenyx Pharmaceutical Inc?
What does OpenAI free version (gpt-3.5-turbo) know about Ultragenyx Pharmaceutical Inc?
| Last request | 14.11.2023
(There is a high chance that below response is an AI hallucination) |
| Well Known | No |
| Description | Ultragenyx Pharmaceutical Inc is a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases. |
| Most Notable Achievements | Ultragenyx has a strong pipeline of potential treatments for rare and ultra-rare diseases. |
| The Most Negative Fact | Ultragenyx has yet to bring any of its products to market. |
| Competition | None |
| Share with friends |
Register your email below to unlock features!
Don't like the AI answers? Who can help me Change them?
What does OpenAI paid version (gpt-4) know about Ultragenyx Pharmaceutical Inc?
| Request date | |
| Well Known | Yes |
| Description | Ultragenyx Pharmaceutical Inc is a biopharmaceutical company that develops and commercializes treatments for rare and ultra-rare genetic diseases. |
| Most Notable Achievements | Ultragenyx has received FDA approval for several innovative therapies that have the potential to significantly improve the lives of patients with rare diseases. |
| The Most Negative Fact | Ultragenyx has faced criticism for the high cost of its treatments, which can be prohibitively expensive for some patients and healthcare systems. |
| Competition | None |
| Share with friends |
What does Google AI (PaLM) know about Ultragenyx Pharmaceutical Inc?
| Last request | 12.12.2023 |
| Well Known | no |
| Description | Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company that develops and commercializes treatments for rare and ultra-rare diseases. |
| Most Notable Achievements | The company's lead product, Soliris, is a treatment for paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder. |
| The Most Negative Fact | The company has been criticized for its high prices for its products. |
| Competition | None |
What does Microsoft Bing AI know about Ultragenyx Pharmaceutical Inc?
| Well Known | Yes |
| Description | yvayte Pelrlcatao i - uastd ceeosnrubrpeacdpm s g of uh etuhen raud fasreaocemlnpicamph inaotefrco e tdeiaodUvltlrxorer a.ss ironIna nlcamc |
| Most Notable Achievements | rnsserert oox nteenyaamaet eoril r-st.t roeee dpsnel U snhilaa tafulpas grifrr aipdatgtan |
| The Most Negative Fact | i tx eo autg oUloer.yfagtntrh nds r asrtmtptybekis aonyc |
| Competition | nNeo |
Register your email below to unlock features!
Looks like you haven't registered an account yet?
Just search for a brand, person or top-list BELOW and register your email on the search results page:
